Evidence map›Paper›PMID 38215438›Full record

ArticleJournal of neurosurgery. Pediatrics2024

The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study.

Ariana Barkley, Eric Butler, Christine Park, Allan Friedman, Daniel Landi, David M Ashley, Darell Bigner, Joshua D Bernstock, Gregory K Friedman, James M Johnston and 1 more

2 registry-linked trialsOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Journal of neurosurgery. Pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02457845 phase1completednot on this map

Phase I Clinical Trial of HSV G207 Alone or With a Single Radiation Dose in Children With Recurrent Supratentorial Brain Tumors

TypeinterventionalSponsorGregory K. Friedman, MDRan2016 to 2024Enrolled13ConditionsSupratentorial Neoplasms, Malignant, Malignant Glioma, Glioblastoma, Anaplastic AstrocytomaArmsG207
NCT03043391 phase1completednot on this map

Phase Ib Study of Oncolytic Polio/Rhinovirus Recombinant Against Recurrent Malignant Glioma in Children

TypeinterventionalSponsorIstari Oncology, Inc.Ran2017 to 2022Enrolled8ConditionsMalignant Glioma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic OligodendrogliomaArmsPolio/Rhinovirus Recombinant (PVSRIPO)
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Protocols and safety profile of convection enhanced delivery in pediatric patients: a systematic review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Pooled it
  2. Targeted therapies in pediatric oncology: A start.Molecular therapy. Oncology · 2026
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Ariana Barkley1Department of Neurosurgery, University of New Mexico, Albuquerque, New Mexico.
Eric ButlerDepartments of3Neurosurgery and.
Christine Park4School of Medicine, Duke University, Durham, North Carolina.
Allan FriedmanDepartments of3Neurosurgery and.
Daniel Landi5Pediatrics, Duke University, Durham, North Carolina.
David M AshleyDepartments of3Neurosurgery and.
Darell BignerDepartments of3Neurosurgery and.
Joshua D Bernstock6Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Gregory K Friedman7Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas; and.
James M JohnstonDepartments of2Neurosurgery and.
Eric M ThompsonDepartments of3Neurosurgery and.
Duke University · USHarvard University · USUniversity of Alabama at Birmingham · USUniversity of Chicago · USUniversity of New Mexico · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRelatively little is known about the safety and accuracy of catheter placement for oncolytic viral therapy in children with malignant brain tumors. Accordingly, this study combines data from two phase I clinical trials that employed viral immunotherapy across two institutions to describe the adverse event profile, safety, and accuracy associated with the stereotactic placement and subsequent removal of intratumoral catheters.

methodsChildren with progressive/recurrent supratentorial malignant tumors were enrolled in two clinical trials (NCT03043391 and NCT02457845) and treated with either the recombinant polio:rhinovirus (lerapolturev) or the genetically modified oncolytic herpesvirus (G207). Age, sex, race, tumor diagnosis, and tumor location were analyzed. Events related to the catheter placement or removal were categorized. A catheter that was either pulled back or could not be used was defined as "misplaced." Neuronavigation software was used to analyze the accuracy of catheter placement for NCT03043391. Descriptive statistics were performed.

resultsNineteen patients were treated across the two completed trials with a total of 49 catheters. The mean ± SD (range) age was 14.1 ± 3.6 (7-19) years. All tumors were grade 3 or 4 gliomas. Nonlobar catheter tip placement included the corpus callosum, thalamus, insula, and cingulate gyrus. Six of 19 patients (31.6%) had minor hemorrhage noted on CT; however, no patients were symptomatic and/or required intervention related to these findings. One of 19 patients had a delayed CSF leak after catheter removal that required oversewing of the surgical site. No patients developed infection or a neurological deficit. In 7 patients with accuracy data, the mean ± SD distance of the planned trajectory (PT) to the catheter tip was 1.57 ± 1.6 mm, the mean angle of the PT to the catheter was 2.43° ± 2.1°, and the greatest distance of PT to the catheter in the parallel plane was 1.54 ± 1.5 mm. Three of 49 (6.1%) catheters were considered misplaced.

conclusionsAlthough instances of minor hemorrhage were encountered, they were clinically asymptomatic. One of 49 catheters required intervention for a CSF leak. Congruent with previous studies in the literature, the stereotactic placement of catheters in these pediatric tumor patients was accurate with approximately 95% of catheters having been adequately placed.

Indexed as

Brain NeoplasmsNeoplasm Recurrence, LocalAdolescentCathetersChildHemorrhageHumansImmunotherapyconvection-enhanced deliveryG207high-grade gliomaintratumoral deliverylerapolturevoncologyoncolytic viruspediatric brain tumorpoliovirus

Identifiers

PMID38215438
PMCPMC10810678
OpenAlexW4390811094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.